Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:33 PM
Ignite Modification Date:
2025-12-24 @ 7:33 PM
NCT ID:
NCT04044703
Eligibility Criteria:
Inclusion Criteria:
* Infants aged 0 - 90 days old
* Suspected infection requiring treatment with vancomycin for 48 hours or more (as determined by the clinical team)
* Post-Menstrual age (PMA) matched to PMA-group from retrospective control group
Exclusion Criteria:
* Infants with corrected gestational age of less than 25 weeks
* Infants weighing less than 500g
* Known allergy to any glycopeptide antibiotic
* Vancomycin administered within the previous 72 hours
* Infants receiving any form of extracorporeal life support
* Renal impairment
* Previously enrolled in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Days
Maximum Age:
90 Days
Study:
NCT04044703
Study Brief:
Protocol Section:
NCT04044703